A novel mass spectrometry method to identify the serum monoclonal light chain component in systemic light chain amyloidosis

被引：0
|
作者：
Faye A. Sharpley
Richa Manwani
Shameem Mahmood
Sajitha Sachchithanantham
Helen J. Lachmann
Julian D. Gillmore
Carol J. Whelan
Marianna Fontana
Philip N. Hawkins
Ashutosh D. Wechalekar
机构：
[1] University College London,National Amyloidosis Centre
来源：
Blood Cancer Journal | / 9卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Serum immunoglobulin heavy/light chain ratios (HevyLite) in patients with systemic AL amyloidosis
    Wechalekar, A. D.
    Harding, S.
    Lachmann, H. J.
    Gillmore, J. D.
    Wassef, N. L.
    Thomas, M.
    Gibbs, S. D. J.
    Sattianayagam, P.
    Whelan, C. J.
    Bradwell, A. R.
    Hawkins, P. N.
    [J]. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2010, 17 : 188 - 189
  • [42] Characterizing the amyloidogenic protein in patients with light chain amyloidosis using mass spectrometry.
    Kourelis, Taxiarchis
    Kohlhagen, Mindy C.
    Mills, John
    Barnidge, David R.
    Dasari, Surendra
    Dispenzieri, Angela
    Murray, David L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [43] Utility of the Serum Free Light Chain Assay in the Diagnosis of Light Chain Amyloidosis in Patients With Heart Failure
    Chang, Ian C.
    Dispenzieri, Angela
    Scott, Christopher G.
    Lin, Grace
    Jaffe, Allan S.
    Klarich, Kyle W.
    Grogan, Martha
    [J]. MAYO CLINIC PROCEEDINGS, 2019, 94 (03) : 447 - 454
  • [44] Analysis of serum immunoglobulin free light chains in primary systemic amyloidosis and light chain deposition disease by nephelometry
    Abraham, RS
    Katzmann, JA
    Clark, RJ
    Dispenzieri, A
    Lust, J
    Bradwell, AR
    Kyle, RA
    [J]. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2001, 8 : 157 - 158
  • [45] Nasolacrimal Light Chain Amyloid Confirmed by Mass Spectrometry Without Systemic Disease
    Wang, Margaret Y.
    Sweeney, Adam R.
    Yen, Michael T.
    [J]. OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2021, 37 (3S): : S112 - S113
  • [46] The prognostic value of the serum free light chain (FLC) assay in systemic amyloidosis is confirmed... and also in other monoclonal gammapathies!
    Macro, Margareth
    [J]. HEMATOLOGIE, 2006, 12 (01): : 12 - 13
  • [47] Ptosis and macroglossia in a woman with systemic light-chain amyloidosis
    Hsiao, Po-Jen
    Chang, Ya-Chieh
    Tsao, Yuan-Heng
    Wu, Kun-Lin
    Kao, Yung-Hsi
    Chan, Jenq-Shyong
    Wang, Chih-Hung
    Lin, Yen-Yue
    Chuu, Chih-Pin
    Lin, Yaoh-Shiang
    [J]. CLINICA CHIMICA ACTA, 2019, 494 : 112 - 115
  • [48] A pharmacist's review of the treatment of systemic light chain amyloidosis
    Hughes, David M.
    Staron, Andrew
    Sanchorawala, Vaishali
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (01) : 187 - 198
  • [49] Systemic AL (light-chain) amyloidosis and the gastrointestinal tract
    Sattianayagam, Prayman
    Gibbs, Simon
    Hawkins, Philip
    Gillmore, Julian
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2009, 44 (11) : 1384 - 1385
  • [50] Systemic Immunoglobulin Light Chain Amyloidosis Involving the Large Intestine
    Swaminathan, Renugadevi
    Igbinedion, Samuel
    Pandit, Sudha
    [J]. ACG CASE REPORTS JOURNAL, 2021, 8 (05)
12345